· 20 years of ophthalmic research experience.
· 16+ years of industry managerial experience in ophthalmic drug discovery and development in both the pharma and CRO sectors.
· Extensive background in molecular cell biology, animal pharmacology, and ophthalmic drug development for both front and back of the eye indications.
· Extensive experience with small molecule, biologics, oligonuceotide, and gene therapy treatment modalities.
· Experience in establishing and running internal IACUC committees and setting up new animal research facilities.